Sign in

Anthony Schuller

@aschuller17.bsky.social
117 followers 157 following 2 posts

Director of Biology @ Interdict Bio | Previously @ Nogales Lab (Berkeley), Schwartz Lab (MIT), Green Lab (Johns Hopkins) | Drug discovery, ribosomes, protein & RNA biochemistry, cryo-EM, cryo-ET.

PostsRepliesMedia
Anthony Schuller @aschuller17.bsky.social · 24/02/2026
Incredibly proud of our small but mighty team at Interdict Bio as we bring the interdictor modality closer to the clinic! Check out our first publication that lays the foundation for context-dependent translation modulators as a therapeutic approach for cancer! www.nature.com/articles/s41...
nature.com
Context-dependent translation inhibition as a cancer therapeutic modality - Nature Communications
Robust protein synthesis by the ribosome is required for rapid cancer growth. Here authors present interdictors, small molecule inhibitors of protein synthesis with context-dependent activity that inh...
0136
Reposted by Anthony Schuller
Derek Lowe @dereklowe.bsky.social · 24/01/2025
This one is mostly about the title subject (featuring a very interesting compound from academia) but it’s also about attacking the NIH:
science.org
Attacking Estrogen-Receptor-Positive Breast Cancer
44718
Reposted by Anthony Schuller
Steven Cheng @scheng23.bsky.social · 10/01/2025
"On a molecular level, our structural studies reveal that interdictors bind in a linkerless heterobifunctional manner to both the rRNA and the nascent peptide chain ... much the way a PROTAC can be modularly designed and constructed"
Figure 3. (A) Representative cryo-EM map of a stalled RNC with a tRNA in the P site, bound to IDB-001.
Inset shows a closeup of the PTC containing the IDB-001 (yellow), P-site tRNA (green), nascent
chain (salmon), rRNA (dark blue), and signal for ions and water molecules (red).
0123
Reposted by Anthony Schuller
Adam Gilbert @adammgilbert65.bsky.social · 17/01/2025
Selective translational stalling is coming of age... doi.org/10.1101/2025...
doi.org
Context-dependent translation inhibition as a novel oncology therapeutic modality
Inhibitors of protein synthesis, including anisomycin, homoharringtonine, and other natural products bind in the peptidyl-transferase center (PTC) of the eukaryotic ribosome to inhibit translation. Re...
021
Anthony Schuller @aschuller17.bsky.social · 22/01/2025
Excited to share the 1st preprint from our incredible team at Interdict Bio as we progress novel, small-molecule sequence-selective inhibitors of translation toward the clinic to address difficult to treat cancers! #ribosome #interdictor Check out the preprint here: www.biorxiv.org/content/10.1...
biorxiv.org
Context-dependent translation inhibition as a novel oncology therapeutic modality
Inhibitors of protein synthesis, including anisomycin, homoharringtonine, and other natural products bind in the peptidyl-transferase center (PTC) of the eukaryotic ribosome to inhibit translation. Re...
11910